Patient enrollment ongoing in phase I study of cytomegalovirus vaccines mRNA-1647 and mRNA-1443 Jan. 4, 2018
Longevity Biotech awarded NIH contract to develop 5A apoA-I mimetic peptide for severe asthma Jan. 4, 2018